Evaluation of carrier detection rates for duchenne and becker muscular dystrophies using serum creatine-kinase(CK) and pyruvate-kinase(PK) through discriminant analysis
- 30 September 1986
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics
- Vol. 25 (2), 219-230
- https://doi.org/10.1002/ajmg.1320250204
Abstract
Serum pyruvate-kinase (PK) and creatine-kinase (CK) determinations have been carried out in a sample of 100 obligate carriers for the Duchenne muscular dystrophy (DMD) gene, 23 obligate carriers for the Becker muscular dystrophy (BMD) gene, and 50 normal adult control women. Blood samples were collected from all subjects three times on three independent occasions and the means of these three determinations were considered for both PK and CK activities in the statistical analysis. Discriminant analysis has shown that, in the group of carriers for the DMD gene, the estimated misclassification frequencies (M.F.) using either serum CK, PK, or both enzymes were: 26.5% for CK alone, 19.5% for PK alone, and 19% for both enzymes. In the group of carriers for the BMD gene, the estimated proportions of M.F. were: 31.7% for CK alone, 23.8% for PK alone, and 20.4% for both enzymes. It is concluded that, although a proportion of carries still remains undetected, the use of serum PK determinations enhances the capability of detecting carriers of both DMD and BMD mainly when compared with serum CK alone.Keywords
This publication has 10 references indexed in Scilit:
- PRENATAL DIAGNOSIS AND CARRIER DETECTION OF DUCHENNE MUSCULAR DYSTROPHY WITH CLOSELY LINKED RFLPsThe Lancet, 1985
- DNA PROBES IN DUCHENNE MUSCULAR DYSTROPHYThe Lancet, 1984
- Duchenne muscular dystrophy carrier detection using logistic discrimination: Serum creatine kinase, hemopexin, pyruvate kinase, and lactate dehydrogenase in combinationAmerican Journal of Medical Genetics, 1982
- The use of concomitant serum pyruvate-kinase (PK) and creatine-phosphokinase (CPK) for carrier detection in Duchenne's muscular dystrophy through discriminant analysisJournal of the Neurological Sciences, 1980
- Serum pyruvate-kinase (PK) and creatine-phosphokinase (CPK) in female relatives and patients with X-linked muscular dystrophies (Duchenne and Becker)Journal of the Neurological Sciences, 1980
- Serum creatine kinase and pyruvate kinase in duchenne muscular dystrophy carrier detectionMuscle & Nerve, 1979
- Serum pyruvate-kinase (PK) and creatine-phosphokinase (CPK) in progressive muscular dystrophiesJournal of the Neurological Sciences, 1978
- Serum pyruvate kinase in muscle disease and carrier statesNeurology, 1974
- SOME NOTES ON DISCRIMINATIONAnnals of Eugenics, 1946